Subclinical hypothyroidism: Is it important in intracytoplasmic sperm injection cycles?

• Published in: Turkish journal of obstetrics and gynecology 2017-06, Vol.14 (2), p.100-105
• Main Authors: Çalışkan, Eray, Ergin, Rahime Nida, Öztekin, Deniz Can, Kars, Bülent, Çakır, Seda, Sofuoğlu, Kenan
• Format: Article
• Language: English
• Subjects: Clinical Investigation; Kadın Hastalıkları; Tıp
• ISSN: 2149-9322; 2149-9330
• DOI: 10.4274/tjod.48108

To compare intracytoplasmic sperm injection (ICSI) outcomes of women with subclinical hypothyroidism with those of euthyroid women. A retrospective case-control study was conducted. Out of 2529 ICSI cycles evaluated, 41 women with hypothyroidism, 28 women with hyperthyroidism, and 128 women with subclinical hyperthyroidism were excluded, and 2336 cycles were analyzed. Women were identified as having subclinical hypothyroidism (case group, n=105) in the presence of a thyroid-stimulating hormone level >4.5 mU/L and normal free T4 and compared with euthyroid controls (n=2231). The mean age, body mass index, day 3 follicle-stimulating hormone level, and antral follicle count of the study patients were similar to the control group (p>0.5). The cycle cancellation rate of the study group was similar to the control group (13.3% vs. 7.6%, p=0.1). The clinical pregnancy rate was 21.2% in the study group, which was significantly lower than the 35.8% in the control group (p=0.04). The take-home baby rate was also significantly lower in the study group compared with the control groups (13.5% vs. 31.4% respectively, p=0.01). Both the clinical pregnancy rate and the take-home baby rate is lower in women with subclinical hypothyroidism at the time of ICSI cycle.